Anti-snoring Device Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Anti-snoring Devices Market Summary
Introduction
Anti-snoring devices, including mandibular advancement devices (MAD), tongue stabilizing devices (TSD), and continuous positive airway pressure (CPAP) devices, are non-invasive solutions to manage snoring and obstructive sleep apnea (OSA). The market is driven by the high prevalence of OSA, lifestyle factors like obesity, increasing health awareness, and an aging population. Innovations such as 3D-printed custom devices and wearable technologies enhance user comfort and efficacy. The global anti-snoring devices market is projected to reach between USD 500 million and USD 900 million in 2025, with a compound annual growth rate (CAGR) of 6.1% to 10.7% through 2030.

Regional Analysis
North America: The U.S. leads due to high OSA prevalence and health awareness, with Canada focusing on homecare solutions.
Europe: Germany, France, and the UK drive demand with advanced sleep clinics and regulatory support.
Asia Pacific: China and India see rapid growth due to rising obesity rates and sleep disorder awareness, while Japan emphasizes high-tech devices.
Rest of the World: Brazil expands in sleep therapy clinics, and the Middle East invests in OSA management.

Application Analysis
Hospitals: Expected growth of 6.0%-10.6%, driven by clinical OSA treatments. Trends focus on CPAP integration.
Sleep Therapy Clinics: Projected growth of 6.2%-10.8%, linked to specialized care. Developments emphasize custom MADs.
Homecare: Anticipated growth of 6.3%-10.9%, tied to patient convenience. Advances prioritize wearable, non-invasive devices.

Type Analysis
Mandibular Advancement Devices (MAD): Expected growth of 6.2%-10.8%, valued for OSA management. Trends highlight 3D-printed custom fits.
Tongue Stabilizing Devices (TSD): Projected growth of 6.0%-10.6%, driven by non-invasive appeal. Advances focus on lightweight materials.
Continuous Positive Airway Pressure (CPAP) Devices: Anticipated growth of 6.3%-10.9%, linked to severe OSA cases. Trends emphasize portable, quiet designs.
Other Device Types: Expected growth of 5.9%-10.5%, covering nasal devices. Innovations prioritize user comfort.

Key Market Players
ResMed, specializing in CPAP devices;
SomnoMed, offering custom MADs;
ProSomnus Sleep Technologies, focusing on 3D-printed devices;
Vivos Therapeutics, advancing OSA therapies;
Philips Respironics, innovating in portable CPAPs;
Airway Management, targeting TSDs;
SnoreRx, providing adjustable MADs;
Tomed GmbH, emphasizing non-invasive solutions;
PureSleep, focusing on homecare devices.

Porter's Five Forces Analysis
Threat of New Entrants: Moderate, due to moderate R&D costs but challenges in achieving clinical efficacy.
Threat of Substitutes: Moderate, with surgical options or lifestyle changes competing, but non-invasive devices are preferred.
Bargaining Power of Buyers: Moderate, with patients seeking effective, affordable devices, but specialized applications limit options.
Bargaining Power of Suppliers: Low, given multiple suppliers for device materials.
Competitive Rivalry: High, with firms competing on customization, comfort, and pricing.

Market Opportunities and Challenges
Opportunities:
OSA, affecting 936 million people globally with 80% undiagnosed, drives demand for accessible devices.
Obesity, impacting 2.1 billion adults, is a key OSA risk factor, boosting market growth.
Growing health awareness, supported by initiatives like World Sleep Day, increases consumer adoption.
An aging population, projected to reach 2.1 billion by 2050, heightens OSA prevalence, sustaining demand.
Technological advancements, like Glidewell’s 3D-printed Silent Nite, improve comfort by 30%.
Emerging markets in Asia offer growth potential.
Challenges:
High costs of advanced devices, like CPAPs priced above USD 1,000, limit adoption in developing regions.
Regulatory approvals, requiring FDA or EU MDR compliance, delay market entry.
Patient compliance issues, particularly with CPAP discomfort, hinder long-term use.
Competition from surgical interventions persists in severe OSA cases. Limited awareness of OSA in low-resource settings slows market growth.

Market News
In May 2024, Glidewell introduced the Silent Nite 3D Sleep Appliance, a 3D-printed solution for snoring and mild OSA.
In January 2024, SnoreLessNow received FDA approval for its Anti-snore Mouth Guard+, an over-the-counter solution developed with Oscimed SA.